Albemarle Investments increased by 13.5% to $1.02B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.1%, from $1.12B to $1.02B. Over 5 years (FY 2020 to FY 2025), Investments shows an upward trend with a 6.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in this area suggests the company is deploying excess capital into long-term wealth-generating assets.
These are investments in securities, joint ventures, or other long-term financial assets that the company intends to hol...
Common in large, diversified healthcare firms that manage significant investment portfolios.
non_current_assets_long_term_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $907.08M | $902.50M | $912.01M | $937.62M | $903.86M | $1.16B | $1.15B | $1.39B | $1.62B | $1.25B | $1.37B | $1.26B | $1.16B | $1.18B | $1.12B | $1.12B | $890.38M | $914.04M | $900.93M | $1.02B |
| QoQ Change | — | -0.5% | +1.1% | +2.8% | -3.6% | +28.2% | -0.7% | +20.9% | +16.5% | -22.7% | +9.2% | -8.1% | -7.8% | +1.6% | -5.2% | +0.6% | -20.8% | +2.7% | -1.4% | +13.5% |
| YoY Change | — | — | — | — | -0.4% | +28.4% | +26.2% | +48.4% | +79.4% | +8.2% | +19.1% | -9.5% | -28.4% | -5.9% | -18.4% | -10.7% | -23.3% | -22.5% | -19.4% | -9.1% |